Following CBIT’s acquisition by Excite Cyber. Credit: Bryan Saba (Excite Technology Services) ASX-listed Excite Cyber has expanded its partnership with a major law enforcement agency providing pro bono assistance in cyber security and digital forensics. For many years the team at CBIT Digital Forensics has assisted this agency pro bono with digital forensics. Following CBIT’s acquisition by Excite Cyber, CEO Bryan Saba confirmed this will continue and be enhanced. Excite Cyber provides highly specialised technical services to government and law enforcement bodies, retrieving and analysing digital evidence essential to modern crime fighting. Excite Cyber is now leveraging its leading digital forensics and cyber security expertise to support national and community causes. The company works alongside law enforcement and legal teams to investigate and combat some of society’s most heinous crimes, including attempted murder, terrorism, child sexual exploitation, and animal cruelty. “Our mission in these cases is to uncover the truth,” Saba said. “When lives, children, or animals are at risk or when national security is threatened, our team doesn’t hesitate to lend their expertise. “We are a values and purpose driven company supporting a safe Australia. We work closely with this law enforcement agency on cases related to murder, terrorism, child exploitation and animal cruelty. For a lot of those cases, we roll up our sleeves and do those cases pro bono donating our skills in the fight against crime.” Excite Cyber’s digital forensics team follows a four-phase digital forensic process: freezing all digital assets, extracting data, ensuring a robust chain of custody, and appearing as expert witnesses when needed, all while maintaining the utmost integrity and neutrality. “Our team contributes to extremely meaningful outcomes protecting children, supporting victims, and defending the truth. It’s emotionally intense but deeply rewarding and is a part of who we are and what we believe in,” he said. SUBSCRIBE TO OUR NEWSLETTER From our editors straight to your inbox Get started by entering your email address below. Please enter a valid email address Subscribe